US 11617761
Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor
granted A61KA61K31/713A61K9/127
Quick answer
US patent 11617761 (Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor) held by The Regents of the University of California expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/713, A61K9/127, A61K9/14